Literature DB >> 25169713

FBXO7-R498X mutation: phenotypic variability from chorea to early onset parkinsonism within a family.

Ayşegül Gündüz1, Aslı Gündoğdu Eken2, Başar Bilgiç3, Hasmet A Hanagasi3, Kaya Bilgüvar4, Murat Günel4, A Nazlı Başak2, Sibel Ertan5.   

Abstract

OBJECTIVE: FBXO7 mutations (PARK 15), first reported in 2008, are among the monogenic causes of early-onset parkinsonism. Classically, PARK 15 was suggested to correspond to previously described pallido-pyramidal syndrome. Here, we report clinical and genetic findings in a unique family of Kurdish origin with an FBXO7 mutation and presenting with diverse clinical phenotypes.
METHODS: The family consisted of 14 members (12 offspring) of whom three were affected. Two of these three siblings were examined in our clinic. DNA samples from the index case and his elder sister were subjected to homozygosity mapping and exomic sequencing.
RESULTS: The index case had progressive speech problems, severe apathy, chorea, and tics at presentation and developed very mild parkinsonism and postural instability after 3 years. His sister had young-onset asymmetric tremor-dominant parkinsonism with some atypical features, such as early development of postural instability, tics, and tachyphemic speech. She died of an akinetic-rigid condition and had not developed chorea. A homozygous R498X mutation was found in both patients (NM_012179; chr22:31,224,440). This result was further confirmed by Sanger sequencing in both patients, their consanguineous parents, and their maternal grandfather; the latter three were found to be heterozygous for the mutation (c.C1492T; p.R498X).
CONCLUSIONS: The family presented here broadens the clinical spectrum of parkinsonism to include tics and chorea, in addition to the parkinsonian-pyramidal phenotype, in connection with FBXO7 mutations and points to an intrafamilial phenotypic variation.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chorea; FBXO7 mutation; PARK-15; Pallido-pyramidal syndrome; Tic

Mesh:

Substances:

Year:  2014        PMID: 25169713     DOI: 10.1016/j.parkreldis.2014.07.016

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  10 in total

1.  Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice.

Authors:  Siv Vingill; David Brockelt; Camille Lancelin; Lars Tatenhorst; Guergana Dontcheva; Christian Preisinger; Nicola Schwedhelm-Domeyer; Sabitha Joseph; Miso Mitkovski; Sandra Goebbels; Klaus-Armin Nave; Jörg B Schulz; Till Marquardt; Paul Lingor; Judith Stegmüller
Journal:  EMBO J       Date:  2016-08-05       Impact factor: 11.598

2.  Is Pallido-Pyramidal Syndrome Still a Useful Concept? No.

Authors:  Hugo Morales-Briceño; Victor S C Fung
Journal:  Mov Disord Clin Pract       Date:  2019-10-14

3.  Myelinating Glia-Specific Deletion of Fbxo7 in Mice Triggers Axonal Degeneration in the Central Nervous System Together with Peripheral Neuropathy.

Authors:  Sabitha Joseph; Siv Vingill; Olaf Jahn; Robert Fledrich; Hauke B Werner; Istvan Katona; Wiebke Möbius; Mišo Mitkovski; Yuhao Huang; Joachim Weis; Michael W Sereda; Jörg B Schulz; Klaus-Armin Nave; Judith Stegmüller
Journal:  J Neurosci       Date:  2019-05-13       Impact factor: 6.167

Review 4.  Genes associated with Parkinson's disease: regulation of autophagy and beyond.

Authors:  Alexandra Beilina; Mark R Cookson
Journal:  J Neurochem       Date:  2015-09-03       Impact factor: 5.372

Review 5.  A Practical Approach to Early-Onset Parkinsonism.

Authors:  Giulietta M Riboldi; Emanuele Frattini; Edoardo Monfrini; Steven J Frucht; Alessio Di Fonzo
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

Review 6.  Ubiquitin and Parkinson's disease through the looking glass of genetics.

Authors:  Helen Walden; Miratul M K Muqit
Journal:  Biochem J       Date:  2017-04-13       Impact factor: 3.857

7.  Loss of FBXO7 results in a Parkinson's-like dopaminergic degeneration via an RPL23-MDM2-TP53 pathway.

Authors:  Simon Rw Stott; Suzanne J Randle; Sara Al Rawi; Paulina A Rowicka; Rebecca Harris; Bethany Mason; Jing Xia; Jeffrey W Dalley; Roger A Barker; Heike Laman
Journal:  J Pathol       Date:  2019-08-06       Impact factor: 7.996

8.  Compound heterozygous variants of the FBXO7 gene resulting in infantile-onset Parkinsonian-pyramidal syndrome in siblings of a Chinese family.

Authors:  Xiaohua Jin; Lisha An; Shengju Hao; Qian Liu; Qinhua Zhang; Xing Wang; Xuan Feng; Chuan Zhang; Xiaofang Cao; Yousheng Yan; Xu Ma
Journal:  J Clin Lab Anal       Date:  2020-04-10       Impact factor: 2.352

9.  Impaired proteasome activity and neurodegeneration with brain iron accumulation in FBXO7 defect.

Authors:  Marta Correa-Vela; Vincenzo Lupo; Marta Montpeyó; Paula Sancho; Anna Marcé-Grau; Jorge Hernández-Vara; Alejandra Darling; Alison Jenkins; Sandra Fernández-Rodríguez; Cristina Tello; Laura Ramírez-Jiménez; Belén Pérez; Ángel Sánchez-Montáñez; Alfons Macaya; María J Sobrido; Marta Martinez-Vicente; Belén Pérez-Dueñas; Carmen Espinós
Journal:  Ann Clin Transl Neurol       Date:  2020-08-06       Impact factor: 4.511

Review 10.  Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson's disease pathogenesis.

Authors:  Stefanie Smolders; Christine Van Broeckhoven
Journal:  Acta Neuropathol Commun       Date:  2020-05-06       Impact factor: 7.801

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.